A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/20371689

Clin. Cancer Res. 2010 Apr 15 16 8 2458-65

Download in:

View as

Triples

General Info

PMID
20371689